Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Sensitive procedure for the amplification of HIV-1 RNA using a combined reverse-transcription and amplification reaction.

× No keyword cloud information.

25 in total

1. Reverse transcriptase and protease sequence evolution in two HIV-1-infected couples.

Authors: Sarah Palmer; Dominique Vuitton; Matthew J Gonzales; Agnés Bassignot; Robert W Shafer
Journal: J Acquir Immune Defic Syndr Date: 2002-11-01 Impact factor: 3.731

2. Rapid and sensitive routine detection of all members of the genus enterovirus in different clinical specimens by real-time PCR.

Authors: Monique Nijhuis; Noortje van Maarseveen; Rob Schuurman; Sandra Verkuijlen; Machiel de Vos; Karin Hendriksen; Anton M van Loon
Journal: J Clin Microbiol Date: 2002-10 Impact factor: 5.948

3. Human immunodeficiency virus type 1 subtype F reverse transcriptase sequence and drug susceptibility.

Authors: C Apetrei; D Descamps; G Collin; I Loussert-Ajaka; F Damond; M Duca; F Simon; F Brun-Vézinet
Journal: J Virol Date: 1998-05 Impact factor: 5.103

4. Human immunodeficiency virus fitness in vivo: calculations based on a single zidovudine resistance mutation at codon 215 of reverse transcriptase.

Authors: J Goudsmit; A De Ronde; D D Ho; A S Perelson
Journal: J Virol Date: 1996-08 Impact factor: 5.103

5. Human immunodeficiency virus type 1 protease genotypes and in vitro protease inhibitor susceptibilities of isolates from individuals who were switched to other protease inhibitors after long-term saquinavir treatment.

Authors: M A Winters; J M Schapiro; J Lawrence; T C Merigan
Journal: J Virol Date: 1998-06 Impact factor: 5.103

6. Human immunodeficiency virus type 1 drug susceptibility determination by using recombinant viruses generated from patient sera tested in a cell-killing assay.

Authors: C A Boucher; W Keulen; T van Bommel; M Nijhuis; D de Jong; M D de Jong; P Schipper; N K Back
Journal: Antimicrob Agents Chemother Date: 1996-10 Impact factor: 5.191

7. Amprenavir inhibitory quotient and virological response in human immunodeficiency virus-infected patients on an amprenavir-containing salvage regimen without or with ritonavir.

Authors: Xavier Duval; Claire Lamotte; Ester Race; Diane Descamps; Florence Damond; François Clavel; Catherine Leport; Gilles Peytavin; Jean-Louis Vilde
Journal: Antimicrob Agents Chemother Date: 2002-02 Impact factor: 5.191

8. Hydroxyurea enhances the activities of didanosine, 9-[2-(phosphonylmethoxy)ethyl]adenine, and 9-[2-(phosphonylmethoxy)propyl]adenine against drug-susceptible and drug-resistant human immunodeficiency virus isolates.

Authors: S Palmer; R W Shafer; T C Merigan
Journal: Antimicrob Agents Chemother Date: 1999-08 Impact factor: 5.191

9. Stochastic processes strongly influence HIV-1 evolution during suboptimal protease-inhibitor therapy.

Authors: M Nijhuis; C A Boucher; P Schipper; T Leitner; R Schuurman; J Albert
Journal: Proc Natl Acad Sci U S A Date: 1998-11-24 Impact factor: 11.205

10. Host-parasite dynamics and outgrowth of virus containing a single K70R amino acid change in reverse transcriptase are responsible for the loss of human immunodeficiency virus type 1 RNA load suppression by zidovudine.

Authors: M D de Jong; J Veenstra; N I Stilianakis; R Schuurman; J M Lange; R J de Boer; C A Boucher
Journal: Proc Natl Acad Sci U S A Date: 1996-05-28 Impact factor: 11.205